GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.'

First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...

Tech Town in North China's Tianjin Fosters Emerging Powerhouses in Biomedical Sector

Sino Bioking (Tianjin) Biological Pharmaceutical Co., Ltd., a tech firm incubated in Beijing's Zhongguancun, known as the country's Silicon Valley, recently announced a major milestone: its ...

Eukarÿs Wins 2025 BioTools Innovator Grand Prize and Joins BARDA’s Elite VANGUARD Program

Press Release Eukarÿs Wins 2025 BioTools Innovator Grand Prize and Joins BARDA’s Elite VANGUARD Program • Awarded the 2025 BioTools Innovator ...

Peptide Therapeutics Market Size to Reach USD 82.19 Billion by 2032; Surging Requirements for Targeted Medicines in Oncology Augment Market Expansion - SNS Insider

According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...

Woolworths-backed biotech All G raises $10m to create ‘bio-identical’ human breast milk

An Australian biotech firm says it has successfully used precision fermentation to reproduce the most vital proteins in human ...

New Frontiers for Early-life Nutrition: All G and Armor Protéines Announce Joint Venture to Scale Human and Bovine Lactoferrin as All G Closes A$10 Million Round

All G's human lactoferrin will be bio-equivalent to the native form with greater than 95% purity. As the company's first recombinant human milk protein, it marks a step toward improving early life ...
The Manila Times

24/7 Market News- Kraig Labs Breakthrough Science is Pivoting to Scalable Business

(GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that Kraig Biocraft Laboratories (OTCQB: ...
AFN

All G raises $6.6m, forms JV with Armor Protéines to scale human and bovine lactoferrin

All G is gearing up to launch its first product—recombinant bovine lactoferrin—in Q1 2026, says CEO Jan Pacas.
Medindia

Saol Therapeutics Has Been Granted a Type A Meeting with the FDA to Determine the Path Forward for SL1009 in Pyruvate Dehydrogenase Complex Deficiency (PDCD)

FDA grants a Type A meeting on December 18th to review new and expanded datasets submitted by Saol to help identify a feasible path forward without the need for an additional clinical trial ROSWELL, ...

Dyadic International, Inc. (DYAI) Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 Transcript

Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...
PharmiWeb

IVD Raw Materials Industry Presents $35.8 Billion Valuation by 2030 - Expansion of POC and Home Diagnostics Strengthens Need for High-Quality Antibodies, Antigens, and Buffers ...

The "IVD Raw Materials - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for IVD Raw Materials was valued at US$27.7 Billion in 2024 and is ...
The Manila Times

Kraig Biocraft Laboratories Secures Usage Rights to Strategic Government-Owned Mulberry Gardens to Support Major Spider Silk Production Expansion

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ('Company' or 'Kraig Labs'), a world leader in spider silk technology*, today announced that it has been granted usage rights to a significant block of ...